Winton Capital »

Abeona Therapeutics shares owned by Winton Capital

Quarter-by-quarter ownership of Abeona Therapeutics (ABEO) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Abeona Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Abeona Therapeutics held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abeona Therapeutics by Winton Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $256k 41k 6.18

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Solstice Advanced Matls Com Shs (SOLS)
Kla Corp Com New (KLAC)
Masco Corporation (MAS)
Cme (CME)
CSX Corporation (CSX)
Incyte Corporation (INCY)
Entegris (ENTG)
Crowdstrike Hldgs Cl A (CRWD)
Public Storage (PSA)
AES Corporation (AES)
Powell Industries (POWL)

View all positions for Winton Capital

Top funds holding Abeona Therapeutics

Nantahala Capital Management
BlackRock
Cable Car Capital
AIGH Capital Management
Vanguard Capital Management
Resources Investment Advisors
AWM Investment Company
Geode Capital Management
Kennedy Capital Management
Goldman Sachs Group
Propel Bio Management
State Street Corporation
Nan Fung Trinity
Diametric Capital
J. Goldman & Co

View all funds holding Abeona Therapeutics